Pennant Return on Tangible Equity 2018-2025 | PNTG
Current and historical return on tangible equity values for Pennant (PNTG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Pennant Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-12-31 | $0.03B | $0.03B | 112.15% |
| 2025-09-30 | $0.03B | $0.06B | 42.19% |
| 2025-06-30 | $0.03B | $0.04B | 68.35% |
| 2025-03-31 | $0.03B | $0.02B | 125.30% |
| 2024-12-31 | $0.02B | $0.00B | 575.00% |
| 2024-09-30 | $0.02B | $-0.02B | -100.00% |
| 2024-06-30 | $0.02B | $-0.01B | -135.71% |
| 2024-03-31 | $0.02B | $-0.01B | -123.08% |
| 2023-12-31 | $0.01B | $-0.01B | -120.93% |
| 2023-09-30 | $0.01B | $-0.01B | -114.29% |
| 2023-06-30 | $0.01B | $-0.01B | -106.12% |
| 2023-03-31 | $0.01B | $-0.01B | -57.14% |
| 2022-12-31 | $0.01B | $-0.01B | -48.00% |
| 2022-09-30 | $0.00B | $-0.01B | -7.69% |
| 2022-06-30 | $0.00B | $-0.01B | 24.49% |
| 2022-03-31 | $0.00B | $-0.01B | -21.82% |
| 2021-12-31 | $0.00B | $-0.02B | -20.69% |
| 2021-09-30 | $0.01B | $-0.01B | -63.16% |
| 2021-06-30 | $0.01B | $-0.01B | -111.63% |
| 2021-03-31 | $0.01B | $-0.01B | -200.00% |
| 2020-12-31 | $0.02B | $0.00B | -400.00% |
| 2020-09-30 | $0.01B | $0.00B | -466.67% |
| 2020-06-30 | $0.01B | $0.00B | 500.00% |
| 2020-03-31 | $0.00B | $0.00B | 400.00% |
| 2019-12-31 | $0.00B | $0.00B | 133.33% |
| 2019-06-30 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.072B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |